Comment from Genedata

Summary: Genedata provides constructive feedback on the draft guidance regarding NGS-based safety assessments for genome editing products. They recommend clarifying the role of NGS in product characterization, expanding the scope of chromosomal integrity analyses beyond translocations, and establishing standards for traceable bioinformatics workflows.